|
|
|
10.10.25 - 08:36
|
XFRA: 7C8: Wiederaufnahme/Resumption (XETRA)
|
|
|
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
INVION LTD 7C8 AU000000IVX4
AB/FROM ONWARDS 10.10.2025...
|
|
|
08.10.25 - 08:21
|
XFRA: 7C8: Aussetzung/Suspension (XETRA)
|
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
INVION LTD 7C8 AU000000IVX4 BAW/UFN...
|
|
|
|
|
20.08.25 - 08:15
|
XFRA: 7C8: Wiederaufnahme/Resumption (XETRA)
|
|
|
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
INVION LTD 7C8 AU000000IVX4
AB/FROM ONWARDS 20.08.2025...
|
|
|
19.08.25 - 09:57
|
XFRA: 7C8: Aussetzung/Suspension (XETRA)
|
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
INVION LTD 7C8 AU000000IVX4 BAW/UFN...
|
|
|
|
|
29.05.25 - 05:48
|
Invion advances skin cancer treatment with positive safety data for INV043 in Phase I/II trial (Small Caps)
|
|
|
Invion (ASX: IVX) has reported no adverse events from the application and use of its lead drug candidate INV043 on the first six patients of a Phase I/II non-melanoma skin cancer (NMSC) trial in Queensland. Data from a safety review committee (SRC) suggested that treatment with the novel photosensitiser was well-tolerated and feedback from clinicians […]
The post Invion advances skin cancer treatment with positive safety data for INV043 in Phase I/II trial appeared first on Small Caps....
|
|
|
04.03.25 - 08:09
|
XFRA : 7C8: Wiederaufnahme/Resumption (XETRA)
|
|
|
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
INVION LTD 7C8 AU000000IVX4
AB/FROM ONWARDS 04.03.2025...
|
|
|
|
|
28.02.25 - 07:54
|
XFRA : 7C8: Aussetzung/Suspension (XETRA)
|
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
INVION LTD 7C8 AU000000IVX4 BAW/UFN...
|
|
|
|
|
03.12.24 - 02:03
|
Australia′s Invion jumps most in 3 yrs as skin cancer treatment trial begins (Reuters EN)
|
|
|
BUZZ-Australia's Invion jumps most in 3 yrs as skin cancer treatment trial begins ** Shares of Invion IVX.AX rise as much as 130.6% to A$0.415, posting their biggest intraday percentage gain since Oct. 28, 2021 ** Stock hits its highest level since July 16 ** Cancer treatment developer says the first patient has been dosed in the early-stage trial...
|
|
|
03.12.24 - 02:01
|
Invion commences dosing in INV043 trial to treat non-melanoma skin cancer (Small Caps)
|
|
|
Clinical-stage life sciences company Invion (ASX: IVX) has dosed the first patient in its Phase I/II non-melanoma skin cancer (NMSC) trial using active pharmaceutical ingredient and lead candidate INV043. The trial will aim to evaluate the safety and efficacy of the topically applied INV043, a novel photosensitiser developed in Australia for use in photodynamic therapy […]
The post Invion commences dosing in INV043 trial to treat non-melanoma skin cancer appeared first on Small Caps....
|
|
|
29.11.24 - 09:27
|
XFRA : 7C8: Wiederaufnahme/Resumption (XETRA)
|
|
|
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
INVION LTD 7C8 AU000000IVX4
AB/FROM ONWARDS 29.11.2024 09:24 CET...
|
|
|
20.11.24 - 08:58
|
XFRA : 7C8: Aussetzung/Suspension (XETRA)
|
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
INVION LTD 7C8 AU000000IVX4 BAW/UFN...
|
|
|
|
|
|
|
19.11.24 - 00:01
|
XFRA : CAPITAL ADJUSTMENT INFORMATION - 20.11.2024 - AU000000IVX4 (XETRA)
|
|
|
Das Instrument 7C8 AU000000IVX4 INVION LTD EQUITY wird cum Kapitalmassnahme gehandelt am 19.11.2024 und ex Kapitalmassnahme am 20.11.2024
The instrument 7C8 AU000000IVX4 INVION LTD EQUITY is traded cum capital adjustment on 19.11.2024 and ex capital adjustment on 20.11.2024...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
